Internal Medicine, Critical Care Medicine · Annandale, VA
NPI
1629084918
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3289 Woodburn Road, 350 Northern Virginia Pulmonary & Critical Care Assoc P
Annandale, VA, 22003
Phone (703) 641-8616
Groups this clinician bills Medicare through
Medicare paid, 2024
$377K
9,109 services
Medicare patients, 2024
680
Average age 76
Drug cost, 2024
$2.8M
3,597 prescriptions
Company payments, 2025
$47K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew D Williams was code 94010 (pulmonary function testing), 1,096 times for 538 patients. In total Matthew D Williams billed 9,109 services in 46 codes, and Medicare paid $377K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94010 Pulmonary Function Testing | Office | 1,096 | 538 | $23.89 | $26K |
| J0517 Injection, benralizumab, 1 mg | Office | 810 | 16 | $132.09 | $107K |
| 99214 Office E&M - Established | Office | 706 | 405 | $108.71 | $77K |
| 99215 Office E&M - Established | Office | 307 | 196 | $151.58 | $47K |
| 99213 Office E&M - Established | Office | 216 | 173 | $76.44 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 141 | 60 | $67.00 | $9,447 |
| 94726 Pulmonary Function Testing | Office | 82 | 77 | $42.47 | $3,482 |
| 94729 Pulmonary Function Testing | Office | 82 | 77 | $43.52 | $3,568 |
| 96372 Injection Administration | Office | 71 | 33 | $9.98 | $708 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 69 | 22 | $0.04 | $2.53 |
| 99223 Hospital E&M - Initial | Facility | 54 | 51 | $143.02 | $7,723 |
| 99233 Hospital E&M - Subsequent | Facility | 51 | 30 | $101.33 | $5,168 |
| 99205 Office E&M - New | Office | 47 | 47 | $173.82 | $8,170 |
| 94060 Pulmonary Function Testing | Office | 31 | 30 | $29.67 | $920 |
| 94618 Pulmonary Function Testing | Office | 29 | 27 | $29.07 | $843 |
By year: 2022 $611K for 7,969 services; 2023 $688K for 15,849 services; 2024 $377K for 9,109 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew D Williams prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 373 prescriptions and refills. In total Matthew D Williams wrote 3,597 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 373 | 527 | 173 | $10K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 311 | 599 | 81 | $378K |
| Prednisone Generic | 272 | 327 | 122 | $1,221 |
| Ipratropium Bromide Generic | 248 | 473 | 107 | $6,526 |
| Azithromycin Generic | 191 | 246 | 80 | $2,531 |
| Montelukast Sodium Generic | 138 | 387 | 44 | $1,819 |
| Breo Ellipta Fluticasone/Vilanterol | 105 | 184 | 26 | $72K |
| Spiriva Respimat Tiotropium Bromide | 96 | 157 | 26 | $79K |
| Advair Hfa Fluticasone Propion/Salmeterol | 83 | 150 | 27 | $55K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 79 | 150 | 22 | $66K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 66 | 125 | 20 | $7,544 |
| Qvar Redihaler Beclomethasone Dipropionate | 65 | 140 | 24 | $35K |
| Dupixent Pen Dupilumab | 62 | 62 | Under 11 | $239K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 60 | 120 | 24 | $75K |
| Eliquis Apixaban | 59 | 127 | 18 | $71K |
Brand drugs: 1,872 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew D Williams $47K ($47K in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $44K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 59 | $44K |
| GlaxoSmithKline, LLC. GSK | 4 | $2,031 |
| Amgen Inc. AMGN | 12 | $262 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $141 |
| Medtronic, Inc. MDT | 1 | $114 |
| Genzyme Corporation SNY | 2 | $71.7 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28.3 |
| Insmed, Inc. INSM | 1 | $18.96 |
| Verona Pharma, Inc. VRNA | 1 | $18.47 |
| Electromed, Inc. ELMD | 1 | $18.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.